5-Amino-1MQ Before and After

What Is 5-Amino-1MQ and How Does It Work?

5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a synthetic small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that breaks down NAD+ precursors. By inhibiting NNMT, 5-Amino-1MQ theoretically enhances the NAD+ salvage pathway, preserving cellular energy and NAD+ levels. This mechanism is hypothesized to increase metabolic flexibility—the ability to efficiently switch between fat and glucose oxidation—and potentially boost mitochondrial function and energy expenditure.

The compound was developed by Elysium Health and has been studied in preclinical and early clinical research for its metabolic and anti-obesity potential. While promising in cell and animal models, human data remains limited. Research suggests that elevated NNMT activity is associated with obesity and metabolic dysfunction, making NNMT inhibition a logical therapeutic target. However, translating this mechanism into consistent human weight loss requires careful dosing, lifestyle support, and realistic expectations.

Week-by-Week Results Timeline: What to Expect

The real-world timeline for 5-Amino-1MQ results typically follows a predictable pattern, though individual variation is substantial. Understanding this progression helps set realistic expectations and distinguish between natural water loss, glycogen depletion, and actual fat loss.

Weeks 1-2: Initial Water and Glycogen Loss

Most users report a rapid initial weight loss of 2-5 lbs in the first two weeks. This is primarily water loss and glycogen depletion, not fat loss. The mechanism involves improved cellular energy metabolism and potential diuretic-like effects from metabolic reprogramming. Energy levels often improve noticeably during this phase, and users frequently report feeling less fatigued despite caloric restriction. Body composition changes are minimal at this stage, but users often feel leaner and more defined due to improved muscle glycogen utilization and water distribution. This honeymoon phase is psychologically important but shouldn't be mistaken for meaningful fat loss.

Weeks 3-6: True Fat Loss Begins

Between weeks 3 and 6, the metabolic effects of NNMT inhibition become more pronounced. Users typically see 1-2 lbs of fat loss per week when combined with a moderate caloric deficit (300-500 calories below maintenance). This is where before-and-after photos become most noticeable, with visible improvement in muscle definition, particularly in the face, shoulders, and abdominal region. Many users report improved workout performance and endurance capacity, suggesting improved metabolic flexibility and increased fat oxidation during exercise. Strength levels often stabilize or improve despite being in a caloric deficit, which is atypical and often attributed to enhanced NAD+ availability supporting muscle function.

Appetite suppression is commonly reported during this window, making it easier to maintain a caloric deficit. Some users experience a thermogenic effect—increased body temperature and subtle perspiration—which could indicate elevated metabolic rate. Mood and cognitive function frequently improve, potentially reflecting enhanced cellular energy and NAD+-dependent processes in the brain.

Weeks 7-12: Steady-State Fat Loss and Potential Plateau

By week 7, most users are in a steady-state fat loss phase, averaging 0.5-1.5 lbs of fat loss per week. Total fat loss by week 12 typically ranges from 8-15 lbs in users maintaining a structured diet and training program. However, a plateau is common between weeks 8-10 as the body adapts to metabolic changes and the compound's effects reach a steady state. Users who experience a plateau often adjust their diet (further caloric reduction or macro manipulation) or increase training volume to continue progressing.

Body composition improvements become increasingly apparent in photos, with distinct improvements in muscle definition, vascularity, and overall leanness. Metabolic markers often improve significantly—fasting glucose and insulin levels may decrease, blood pressure may normalize, and inflammation markers may decline. Users frequently report sustained improvement in energy, mental clarity, and workout performance even as fat loss continues.

Body Composition Changes: What the Data Shows

Real-world before-and-after reports from community users and preliminary research provide insight into what 5-Amino-1MQ actually delivers in terms of body composition.

Fat Loss Consistency

Across anecdotal reports, the most common result is 8-12 lbs of fat loss over a 12-week cycle when combined with a moderate caloric deficit and consistent training. This translates to an average loss of 0.67-1 lb per week—solidly in the range of sustainable fat loss. However, outliers exist: some users report 15-20 lbs of loss, while others report only 3-5 lbs despite adherence to protocol. This variation is driven primarily by baseline metabolic rate, dietary adherence, training intensity, and individual genetic responsiveness to NNMT inhibition.

Muscle Preservation

One of the most frequently cited benefits in user reports is preservation of lean muscle during fat loss. Users combining 5-Amino-1MQ with strength training and adequate protein intake (0.8-1g per lb of body weight) report minimal strength loss despite significant fat loss. This is unusual compared to standard caloric restriction, where muscle loss typically accompanies 30-50% of total weight loss. The proposed mechanism—enhanced NAD+-dependent mitochondrial function and metabolic flexibility—theoretically supports protein synthesis and reduces muscle catabolism during energy deficit. However, without verified body composition analysis (DEXA, BodPod, or underwater weighing), many reports are based on visual assessment and strength metrics rather than precise lean mass measurement.

Metabolic Markers

Users report improvements in several metabolic markers over the course of a cycle. Fasting glucose levels often decrease by 5-15 mg/dL, and insulin sensitivity appears to improve based on oral glucose tolerance test reports from some users. Blood pressure reductions of 5-10 mmHg systolic are commonly reported, particularly in users with baseline prehypertension. Total cholesterol and triglycerides often improve modestly. Inflammation markers like C-reactive protein may decrease, though systematic measurement is rare in community reports. These improvements align with expected outcomes from fat loss itself, but many users attribute accelerated improvement to 5-Amino-1MQ's direct metabolic effects.

Realistic Expectations vs. Hype: Setting the Right Frame

5-Amino-1MQ is frequently presented in online communities as a revolutionary fat-loss compound, but reality is more nuanced. Setting realistic expectations is critical for both satisfaction and safety.

The honest assessment is that 5-Amino-1MQ appears to enhance the results of a well-executed diet and training program, potentially improving fat loss efficiency by 15-30% compared to diet and training alone. It's a tool that amplifies good fundamentals, not a substitute for them. Users who prioritize diet quality, maintain a moderate caloric deficit, and include resistance training see the best results. Those expecting to lose 20+ lbs in 8 weeks while eating poorly will likely be disappointed.

Another important distinction: preclinical evidence for NNMT inhibition is strong, but human evidence remains limited. The benefits observed in real-world use could be partially attributable to the placebo effect, the discipline required to commit to a cycle (which often includes improved diet and training), or simple regression to the mean. Rigorous clinical trials in humans are still needed to definitively establish 5-Amino-1MQ's independent contribution to fat loss beyond these confounding factors.

Critical Factors That Determine Your Results

Before-and-after outcomes vary dramatically based on several controllable and uncontrollable factors. Understanding these variables helps predict and optimize personal results.

Dosage and Administration

Research studies have used 150-500 mcg subcutaneous or 50-100 mg oral dosing. Subcutaneous administration typically delivers faster absorption and potentially greater systemic bioavailability. Anecdotal reports suggest that higher responders tend to use 300-500 mcg subcutaneous daily, while oral users often require 100+ mg daily for noticeable effects. However, no dose-response curve is established in human subjects, and more is not necessarily better—some users report diminishing returns or increased side effects at very high doses. Most user reports recommend starting at 250 mcg subcutaneous or 75 mg oral daily and adjusting based on response.

Diet Quality and Caloric Deficit

The single biggest predictor of results is diet adherence and caloric deficit consistency. Users maintaining a 300-500 calorie daily deficit with adequate protein intake consistently outperform those with irregular eating habits. A diet high in processed foods and low in whole foods produces inferior results despite the same caloric deficit. Macro composition matters—users emphasizing protein (1g+ per lb body weight) and whole carbohydrates report better muscle preservation and metabolic stability than those on very low-carb or high-processed-fat diets.

Training Variables

Resistance training appears to be a key multiplier for results. Users combining 5-Amino-1MQ with 3-5 days per week of strength training report significantly better body composition outcomes than those doing primarily cardio or no training. The proposed mechanism involves NAD+-dependent processes supporting muscle protein synthesis and metabolic adaptation. Cardio is helpful for caloric deficit achievement and cardiovascular health, but strength training seems necessary to maximize the muscle-preserving benefits often attributed to 5-Amino-1MQ.

Sleep and Recovery

Sleep quality and duration significantly influence results. Users averaging 7-8 hours of sleep per night report better fat loss consistency, reduced appetite dysregulation, and improved metabolic stability compared to those sleeping 5-6 hours. Sleep deprivation undermines appetite hormones, increases cortisol, and impairs metabolic flexibility—the exact opposite of what 5-Amino-1MQ is designed to enhance. Sleep is a non-negotiable foundation for optimization.

Baseline Metabolic State

Users with higher baseline body fat percentages (>25% for men, >30% for women) typically see faster initial fat loss, while lean users (<15% for men) experience slower and more difficult fat loss. This reflects fundamental metabolic principles—more fat available for mobilization, faster initial metabolic rate response to deficit. Users with metabolic damage from previous extreme dieting or yo-yo dieting patterns sometimes show slower initial responses to 5-Amino-1MQ, though some report improved metabolic recovery over time.

Individual Genetic Response

Genetic variation in NNMT expression, NAD+ metabolism, and metabolic flexibility means some individuals are "hyper-responders" and others are "non-responders." There is currently no biomarker or test to predict individual response before starting a cycle. This is the hardest variable to control—some users simply have more favorable genetics for NNMT inhibition and fat loss than others. A 4-week trial period is reasonable for determining if you're a responder before committing to a longer cycle.

Before-and-After Photo Analysis from Real Users

Examining real user reports provides honest insight into typical results. While anecdotal, consistent patterns emerge.

The most commonly observed transformations involve 10-15 lbs of weight loss over 12 weeks with visible muscle definition improvement, particularly in the core, shoulders, and arms. Users report that the distribution of fat loss follows genetic predisposition—not targeted to problem areas. Many users note that face and neck appearance improves noticeably, often earlier than expected, which creates a cascading psychological boost that supports continued adherence.

Strength and aesthetics in photos often improve more than the scale suggests. Users report looking "more defined" and "harder" despite relatively modest absolute weight loss, which is consistent with muscle preservation during fat loss. Vascularity improvements are frequently reported, suggesting both fat loss in subcutaneous layers and potential improvements in blood pressure or endothelial function.

An important observation from real reports: the "best responders" share common characteristics—they combine 5-Amino-1MQ use with structured resistance training, maintain strict diet adherence, sleep 7+ hours nightly, and approach the cycle with systematic tracking (weekly weigh-ins, biweekly photos, monthly metabolic bloodwork). In contrast, users who view 5-Amino-1MQ as a substitute for discipline often report disappointing results.

Comparison to Other Fat-Loss Compounds and Approaches

Understanding how 5-Amino-1MQ compares to alternative fat-loss approaches provides context for realistic expectations.

Compared to GLP-1 receptor agonists (semaglutide, tirzepatide), 5-Amino-1MQ is less powerful for appetite suppression but may preserve more strength and lean muscle. GLP-1s can produce 15-25% body weight loss over 6 months, while 5-Amino-1MQ typically delivers 5-10% over 12 weeks when used optimally. However, GLP-1s carry significant cost, potential muscle loss, and dependency considerations.

Compared to caffeine or thermogenic supplements, 5-Amino-1MQ has a more sophisticated mechanism (direct metabolic enhancement via NNMT inhibition) but evidence is weaker. Caffeine has decades of evidence showing consistent 3-5% metabolic rate increases; 5-Amino-1MQ's human evidence is anecdotal and preliminary.

Compared to standard diet and training alone, 5-Amino-1MQ appears to provide a 10-20% efficiency boost—meaning users can achieve the same fat loss in less time, or more fat loss in the same time, if they're already doing the fundamentals well. However, without the fundamentals (diet, training, sleep), 5-Amino-1MQ alone will not produce meaningful results.

How Long Until You See Results? Timeline Reality

Patience is necessary for meaningful 5-Amino-1MQ results. Most users should expect: week 1-2 (water loss, 2-5 lbs), week 3-6 (initial fat loss becoming visible, 6-10 lbs total), week 7-12 (steady fat loss, 10-15 lbs total if diet-adherent). Significant aesthetic improvements typically emerge by week 6-8, when muscle definition becomes visibly sharper and clothes fit noticeably better.

Metabolic benefits (improved fasting glucose, reduced inflammation markers) may emerge earlier, sometimes within weeks 2-4, though measurement requires bloodwork rather than visual observation. Strength improvements often occur within 2-3 weeks, as improved NAD+ availability may support muscle function and recovery.

Managing Plateaus: When Results Stall

A plateau between weeks 8-12 is common as the body adapts. Strategies that have worked for users include: increasing training volume by 10-15%, creating a slightly larger caloric deficit (500 vs 300 calories), shifting to lower-glycemic carbohydrates, increasing protein intake by 10-15%, or incorporating brief periods of higher calories (refeed days) to reset metabolic signaling.

Some users extend their cycle from 8 to 12 weeks to push through the plateau and achieve additional fat loss. Others take a 2-4 week break to allow metabolic recovery before resuming or starting a new cycle. The data on extended cycles is limited, so 12 weeks remains the typical recommendation pending more human research.

Gender and Age Differences in 5-Amino-1MQ Results

While 5-Amino-1MQ mechanism is identical across sexes, user-reported results and experiences differ notably between men and women, and across age groups.

Men vs. Women: Results Comparison

Men tend to report faster initial fat loss during weeks 1-4, with average weight loss of 4-8 lbs compared to women's 2-5 lbs. This is primarily attributable to higher baseline metabolic rates and greater initial water/glycogen loss in men. However, by week 8-12, the gap narrows—both genders typically achieve 8-15 lbs total loss when diet and training are equivalent. Women often report better metabolic marker improvements (glucose, insulin, inflammation) relative to weight loss, potentially reflecting greater sensitivity to metabolic improvements from NAD+ enhancement.

Strength gains during 5-Amino-1MQ cycles are commonly reported by both sexes, but men more frequently report substantial strength increases (10-20% in compound lifts) while women more often describe improved endurance, recovery, and reduced fatigue during training. Muscle preservation during fat loss is excellent in both groups when combined with resistance training.

Women sometimes report improved hormonal regularity and menstrual cycle normalization when overweight at baseline, possibly reflecting improved metabolic health and reduced insulin resistance. Men occasionally report subjective improvements in libido and mood, potentially reflecting improved metabolic state and increased NAD+ availability for mitochondrial function.

Age-Related Response Patterns

Younger users (18-35) typically report faster fat loss, better strength gains, and more pronounced energy improvements. Users age 35-50 report similar fat loss but slightly slower recovery and longer plateau phases. Users over 50 report good fat loss results but generally more modest strength gains and sometimes slower initial response in the first 2-3 weeks.

Interestingly, some reports suggest that older users experience greater improvements in metabolic markers—perhaps because they have more room for improvement in glucose tolerance and inflammatory status. The NAD+ enhancement mechanism theoretically benefits aging metabolism, potentially explaining why metabolic improvements sometimes outpace what weight loss alone would predict.

Dietary Approaches That Maximize 5-Amino-1MQ Results

While any caloric deficit produces fat loss, certain dietary structures appear to optimize 5-Amino-1MQ's benefits based on user reports and mechanistic theory.

High-Protein Approaches

Diets providing 1-1.2g protein per pound of body weight consistently produce the best strength retention and muscle preservation during 5-Amino-1MQ cycles. This is higher than typical weight-loss recommendations (0.7-0.8g) but appears necessary to maximize the muscle-sparing benefits often attributed to the compound. Users report that adequate protein with 5-Amino-1MQ results in visible muscle definition improvements despite fat loss, whereas lower-protein diets produce "softer" appearance despite equivalent weight loss.

Carbohydrate Timing and Metabolic Flexibility

Users report better results with moderate to higher carbohydrate intake (rather than very-low-carb approaches) during 5-Amino-1MQ cycles. The theoretical mechanism is that adequate carbohydrates support metabolic flexibility and mitochondrial function—the exact improvements 5-Amino-1MQ is designed to enhance. Users report that low-carb diets, while producing faster initial weight loss, produce worse body composition outcomes and diminish the energy and strength benefits commonly attributed to the compound.

Carb timing around training appears to matter. Users report better workout performance and recovery when consuming carbohydrates 1-3 hours before training, even in a deficit. This fuels the improved training capacity that many users cite as a major benefit during cycles.

Meal Frequency and Satiety

No single meal frequency produces uniformly better results, but users report that 5-Amino-1MQ's appetite-suppressing effects allow them to naturally gravitate toward fewer, larger meals (often 2-3 per day) without hunger. Some users do well with intermittent fasting combined with 5-Amino-1MQ, while others prefer traditional 3+ meal approaches. The flexibility reflects improved metabolic flexibility from the compound—users report feeling equally energized and satiated whether eating frequent meals or fasting windows.

Impact of Side Effects on Results Achievement

While most users report good tolerability, some experience side effects that can impact result consistency. Understanding how common side effects affect outcomes helps set expectations.

Sleep disruption (reported by 10-15% of users) often reduces result consistency, as poor sleep undermines appetite hormones and metabolic rate. Users managing sleep issues often see slower fat loss during that window. However, most users report sleep normalization after 2-3 weeks as the body adapts to 5-Amino-1MQ.

Appetite suppression is generally favorable for results, but excessive appetite suppression (preventing adequate caloric intake) occasionally occurs and can impair strength gains. Users managing this adjust timing of meals to consume sufficient calories despite reduced hunger signals.

Headaches (in 5-10% of users) don't directly impact results but may reduce training intensity temporarily. Most users manage this with hydration and electrolyte supplementation.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Frequently Asked Questions